These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37778894)

  • 1. Bacterial infections as a risk factor for non-neoplastic portal vein thrombosis development in cirrhotic patients.
    Dalbeni A; Cattazzo F; De Marco L; Bevilacqua M; Zoncapè M; Lombardi R; Stupia R; Mantovani A; Sacerdoti D
    Dig Liver Dis; 2024 Mar; 56(3):477-483. PubMed ID: 37778894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors associated with portal vein thrombosis in liver cirrhosis: A case-control study.
    Nadinskaia MY; Kodzoeva KB; Ulyanova KA; Volkova AS; Rogacheva SI; Dekhanov AS; Strelkova DA; Ivashkin VT
    Ter Arkh; 2019 Mar; 91(2):73-81. PubMed ID: 31094175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and clinical presentation of portal vein thrombosis in cirrhotic patients.
    Cagin YF; Atayan Y; Erdogan MA; Dagtekin F; Colak C
    Hepatobiliary Pancreat Dis Int; 2016 Oct; 15(5):499-503. PubMed ID: 27733319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visceral fat is associated with cirrhotic portal vein thrombosis.
    Hernández-Conde M; Llop E; Fernández-Carrillo C; Perelló C; López-Gómez M; Abad J; Martínez-Porras JL; Fernández-Puga N; Calleja JL
    Expert Rev Gastroenterol Hepatol; 2019 Oct; 13(10):1017-1022. PubMed ID: 31393183
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute Portal Vein Thrombosis Predicts Concomitant Diagnosis of Hepatocellular Carcinoma in Cirrhotic Patients.
    Khoury T; Massarwa M; Hazou W; Daher S; Hakimian D; Benson AA; Ashqar T; Mahamid M; Yaari S
    J Gastrointest Cancer; 2019 Dec; 50(4):759-762. PubMed ID: 30043228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single hospital study on portal vein thrombosis in cirrhotic patients - clinical characteristics & risk factors.
    Chen H; Trilok G; Wang F; Qi X; Xiao J; Yang C
    Indian J Med Res; 2014 Feb; 139(2):260-6. PubMed ID: 24718401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis.
    Amitrano L; Guardascione MA; Brancaccio V; Margaglione M; Manguso F; Iannaccone L; Grandone E; Balzano A
    J Hepatol; 2004 May; 40(5):736-41. PubMed ID: 15094219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and clinical characteristics of advanced portal vein thrombosis in cirrhotic patients with gastroesophageal variceal hemorrhage.
    Rao CY; Xue CY; Fang QQ; Wu L; Huang XQ; Chen Y; Chen SY; Li F
    J Dig Dis; 2023 Apr; 24(4):284-292. PubMed ID: 37246244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased portal vein velocity is predictive of the development of portal vein thrombosis: A matched case-control study.
    Stine JG; Wang J; Shah PM; Argo CK; Intagliata N; Uflacker A; Caldwell SH; Northup PG
    Liver Int; 2018 Jan; 38(1):94-101. PubMed ID: 28632958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis.
    Luca A; Miraglia R; Caruso S; Milazzo M; Sapere C; Maruzzelli L; Vizzini G; Tuzzolino F; Gridelli B; Bosch J
    Gut; 2011 Jun; 60(6):846-52. PubMed ID: 21357252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-neoplastic Portal Vein Thrombosis in HCV Cirrhosis Patients: Is it an Immuno-Inflammatory Disorder?
    Abu El-Makarem MA; El-Akad AF; Elian MM; Sherif TM; El-Shaheed RA; Abd El Fatah AS; Sayed DM; Bakry RM; Mahmoud AM
    Ann Hepatol; 2017; 16(4):574-583. PubMed ID: 28611261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nontumorous Portal Vein Thrombosis in Liver Cirrhosis: Possible Role of β-Blockers.
    Giannitrapani L; Granà W; Licata A; Schiavone C; Montalto G; Soresi M
    Med Princ Pract; 2018; 27(5):466-471. PubMed ID: 30107378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, predictive factors and clinical significance of development of portal vein thrombosis in cirrhosis: A prospective study.
    Noronha Ferreira C; Marinho RT; Cortez-Pinto H; Ferreira P; Dias MS; Vasconcelos M; Alexandrino P; Serejo F; Pedro AJ; Gonçalves A; Palma S; Leite I; Reis D; Damião F; Valente A; Xavier Brito L; Baldaia C; Fatela N; Ramalho F; Velosa J
    Liver Int; 2019 Aug; 39(8):1459-1467. PubMed ID: 31021512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural course of extrahepatic nonmalignant partial portal vein thrombosis in patients with cirrhosis.
    Luca A; Caruso S; Milazzo M; Marrone G; Mamone G; Crinò F; Maruzzelli L; Miraglia R; Floridia G; Vizzini G
    Radiology; 2012 Oct; 265(1):124-32. PubMed ID: 22891357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Portal vein thrombosis in patients with cirrhosis: just a common finding or a predictor of poor outcome?
    Borjas-Almaguer OD; Cortez-Hernández CA; González-Moreno EI; Bosques-Padilla FJ; González-González JA; Garza AA; Martínez-Segura JA; García-Compean D; Alejandre-Loya JV; García-García J; Delgado-García G; Maldonado-Garza HJ
    Ann Hepatol; 2016 Nov-Dec 2016; 15(6):902-906. PubMed ID: 27740524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical features of liver cirrhosis complicated by portal vein thrombosis and related risk factors].
    Lin GS; Xu Q; Zhao SY; Zhang YX
    Zhonghua Gan Zang Bing Za Zhi; 2016 Jul; 24(7):513-517. PubMed ID: 27784429
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk Factors of Portal Vein Thrombosis after Devascularization Treatment in Patients with Liver Cirrhosis: A Nested Case-Control Study.
    Lu S; Hu G; Chen S; Wang J
    Biomed Res Int; 2020; 2020():9583706. PubMed ID: 32908928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Portal vein thrombosis and liver cirrhosis: Long-term anticoagulation is effective and safe.
    Bergère M; Erard-Poinsot D; Boillot O; Valette PJ; Guillaud O; Chambon-Augoyard C; Dumortier J
    Clin Res Hepatol Gastroenterol; 2019 Aug; 43(4):395-402. PubMed ID: 30578107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of nonselective beta blockers is a risk factor for portal vein thrombosis in cirrhotic patients.
    Zampino R; Lebano R; Coppola N; Macera M; Grandone A; Rinaldi L; De Sio I; Tufano A; Stornaiuolo G; Adinolfi LE; Durante-Mangoni E; Battista GG; Niglio A
    Saudi J Gastroenterol; 2018; 24(1):25-29. PubMed ID: 29451181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What we should know about portal vein thrombosis in cirrhotic patients: a changing perspective.
    Ponziani FR; Zocco MA; Garcovich M; D'Aversa F; Roccarina D; Gasbarrini A
    World J Gastroenterol; 2012 Sep; 18(36):5014-20. PubMed ID: 23049208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.